These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer. Tafra L; Cheng Z; Uddo J; Lobrano MB; Stein W; Berg WA; Levine E; Weinberg IN; Narayanan D; Ross E; Beylin D; Yarnall S; Keen R; Sawyer K; Van Geffen J; Freimanis RL; Staab E; Adler LP; Lovelace J; Shen P; Stewart J; Dolinsky S Am J Surg; 2005 Oct; 190(4):628-32. PubMed ID: 16164937 [TBL] [Abstract][Full Text] [Related]
3. Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography? Bitencourt AG; Lima EN; Macedo BR; Conrado JL; Marques EF; Chojniak R Eur Radiol; 2017 May; 27(5):1893-1900. PubMed ID: 27585658 [TBL] [Abstract][Full Text] [Related]
5. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Berg WA; Weinberg IN; Narayanan D; Lobrano ME; Ross E; Amodei L; Tafra L; Adler LP; Uddo J; Stein W; Levine EA; Breast J; 2006; 12(4):309-23. PubMed ID: 16848840 [TBL] [Abstract][Full Text] [Related]
6. Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG. Murthy K; Aznar M; Thompson CJ; Loutfi A; Lisbona R; Gagnon JH J Nucl Med; 2000 Nov; 41(11):1851-8. PubMed ID: 11079494 [TBL] [Abstract][Full Text] [Related]
7. Positron emission mammography in the diagnosis of breast cancer. Is maximum PEM uptake value a valuable threshold for malignant breast cancer detection? Müller FH; Farahati J; Müller AG; Gillman E; Hentschel M Nuklearmedizin; 2016; 55(1):15-20. PubMed ID: 26627876 [TBL] [Abstract][Full Text] [Related]
8. Positron emission mammography: diagnostic imaging and biopsy on the same day. Argus A; Mahoney MC AJR Am J Roentgenol; 2014 Jan; 202(1):216-22. PubMed ID: 24370147 [TBL] [Abstract][Full Text] [Related]
9. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging. Schilling K; Narayanan D; Kalinyak JE; The J; Velasquez MV; Kahn S; Saady M; Mahal R; Chrystal L Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):23-36. PubMed ID: 20871992 [TBL] [Abstract][Full Text] [Related]
10. Newly-Developed Positron Emission Mammography (PEM) Device for the Detection of Small Breast Cancer. Yanai A; Itoh M; Hirakawa H; Yanai K; Tashiro M; Harada R; Yoshikawa A; Yamamoto S; Ohuchi N; Ishida T Tohoku J Exp Med; 2018 May; 245(1):13-19. PubMed ID: 29731479 [TBL] [Abstract][Full Text] [Related]
11. Positron Emission Mammography for Breast Cancer in Rajavithi Hospital. Boonyaleepan A J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S130-5. PubMed ID: 27266227 [TBL] [Abstract][Full Text] [Related]
12. The positron emission mammography/tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements. Raylman RR; Majewski S; Smith MF; Proffitt J; Hammond W; Srinivasan A; McKisson J; Popov V; Weisenberger A; Judy CO; Kross B; Ramasubramanian S; Banta LE; Kinahan PE; Champley K Phys Med Biol; 2008 Feb; 53(3):637-53. PubMed ID: 18199907 [TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer. Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Kalinyak JE AJR Am J Roentgenol; 2012 Jan; 198(1):219-32. PubMed ID: 22194501 [TBL] [Abstract][Full Text] [Related]
15. Background ¹⁸F-FDG uptake in positron emission mammography (PEM): correlation with mammographic density and background parenchymal enhancement in breast MRI. Koo HR; Moon WK; Chun IK; Eo JS; Jeyanth JX; Chang JM; Cho N; Kang KW Eur J Radiol; 2013 Oct; 82(10):1738-42. PubMed ID: 23806533 [TBL] [Abstract][Full Text] [Related]
16. Mammography-guided stereotactic fine-needle aspiration cytology of nonpalpable breast lesions: prospective comparison with surgical biopsy results. Fajardo LL; Davis JR; Wiens JL; Trego DC AJR Am J Roentgenol; 1990 Nov; 155(5):977-81. PubMed ID: 2120967 [TBL] [Abstract][Full Text] [Related]
17. Imaging sensitivity of dedicated positron emission mammography in relation to tumor size. Eo JS; Chun IK; Paeng JC; Kang KW; Lee SM; Han W; Noh DY; Chung JK; Lee DS Breast; 2012 Feb; 21(1):66-71. PubMed ID: 21871801 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of imaging sensitivity of positron emission mammography and whole-body PET in relation to tumor size. Yamamoto Y; Ozawa Y; Kubouchi K; Nakamura S; Nakajima Y; Inoue T Clin Nucl Med; 2015 Jan; 40(1):21-5. PubMed ID: 25423346 [TBL] [Abstract][Full Text] [Related]
19. Interpretation of positron emission mammography: feature analysis and rates of malignancy. Narayanan D; Madsen KS; Kalinyak JE; Berg WA AJR Am J Roentgenol; 2011 Apr; 196(4):956-70. PubMed ID: 21427350 [TBL] [Abstract][Full Text] [Related]
20. Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience. Rosen EL; Turkington TG; Soo MS; Baker JA; Coleman RE Radiology; 2005 Feb; 234(2):527-34. PubMed ID: 15671006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]